Literature DB >> 19933856

Accumulation of CD11b+ lung dendritic cells in response to fungal infection results from the CCR2-mediated recruitment and differentiation of Ly-6Chigh monocytes.

John J Osterholzer1, Gwo-Hsiao Chen, Michal A Olszewski, Jeffrey L Curtis, Gary B Huffnagle, Galen B Toews.   

Abstract

Pulmonary clearance of the encapsulated yeast Cryptococcus neoformans is associated with the CCR2-mediated accumulation of lung dendritic cells (DC) and the development of a T1 adaptive immune response. The objective of this study was to identify the circulating DC precursor(s) responsible for this large increase in lung DC numbers. An established murine model was used to evaluate putative DC precursors in the blood, bone marrow, and lungs of CCR2(+/+) mice and CCR2(-/-) mice throughout a time course following infection with C. neoformans. Results demonstrate that numbers of Ly-6C(high) monocytes increased in parallel in the peripheral blood and lungs of CCR(+/+) mice, whereas CD11c(+) MHC class II(+) pre-DC were 10-fold less prevalent in the peripheral blood and did not differ between the two strains. Accumulation of Ly-6C(high) monocytes correlated with a substantial increase in the numbers of CD11b(+) DC in the lungs of infected CCR2(+/+) mice. Comparative phenotypic analysis of lung cells recovered in vivo suggests that Ly-6C(high) monocytes differentiate into CD11b(+) DC in the lung; differentiation is associated with up-regulation of costimulatory molecules and decreased Ly-6C expression. Furthermore, in vitro experiments confirmed that Ly-6C(high) monocytes differentiate into CD11b(+) DC. Accumulation of Ly-6C(high) monocytes and CD11b(+) DC was not attributable to their proliferation in situ. We conclude that the CCR2-mediated accumulation of CD11b(+) DC in the lungs of Cryptococcus-infected mice is primarily attributable to the continuous recruitment and differentiation of Ly-6C(high) monocytes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19933856      PMCID: PMC4043300          DOI: 10.4049/jimmunol.0902823

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  69 in total

1.  Attenuation of allergen-induced responses in CCR6-/- mice is dependent upon altered pulmonary T lymphocyte activation.

Authors:  Steven K Lundy; Sergio A Lira; Jetse J Smit; Donald N Cook; Aaron A Berlin; Nicholas W Lukacs
Journal:  J Immunol       Date:  2005-02-15       Impact factor: 5.422

Review 2.  Dendritic cells: translating innate to adaptive immunity.

Authors:  R M Steinman; H Hemmi
Journal:  Curr Top Microbiol Immunol       Date:  2006       Impact factor: 4.291

3.  Chemokine receptor CCR2 but not CCR5 or CCR6 mediates the increase in pulmonary dendritic cells during allergic airway inflammation.

Authors:  Lander J Robays; Tania Maes; Serge Lebecque; Sergio A Lira; William A Kuziel; Guy G Brusselle; Guy F Joos; Karim V Vermaelen
Journal:  J Immunol       Date:  2007-04-15       Impact factor: 5.422

4.  Transient neutralization of tumor necrosis factor alpha can produce a chronic fungal infection in an immunocompetent host: potential role of immature dendritic cells.

Authors:  Amy C Herring; Nicole R Falkowski; Gwo-Hsiao Chen; Rod A McDonald; Galen B Toews; Gary B Huffnagle
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

5.  In vivo role of dendritic cells in a murine model of pulmonary cryptococcosis.

Authors:  Karen L Wozniak; Jatin M Vyas; Stuart M Levitz
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

6.  Distinct differentiation potential of blood monocyte subsets in the lung.

Authors:  Limor Landsman; Chen Varol; Steffen Jung
Journal:  J Immunol       Date:  2007-02-15       Impact factor: 5.422

Review 7.  Cells and cytokines in pulmonary cryptococcosis.

Authors:  G B Huffnagle; M F Lipscomb
Journal:  Res Immunol       Date:  1998 May-Jun

8.  The gamma interferon receptor is required for the protective pulmonary inflammatory response to Cryptococcus neoformans.

Authors:  Gwo-Hsiao Chen; Roderick A McDonald; Jason C Wells; Gary B Huffnagle; Nicholas W Lukacs; Galen B Toews
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

9.  Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites.

Authors:  Chia-Lin Tsou; Wendy Peters; Yue Si; Sarah Slaymaker; Ara M Aslanian; Stuart P Weisberg; Matthias Mack; Israel F Charo
Journal:  J Clin Invest       Date:  2007-03-15       Impact factor: 14.808

10.  In vivo depletion of lung CD11c+ dendritic cells during allergen challenge abrogates the characteristic features of asthma.

Authors:  Leonie S van Rijt; Steffen Jung; Alex Kleinjan; Nanda Vos; Monique Willart; Catherine Duez; Henk C Hoogsteden; Bart N Lambrecht
Journal:  J Exp Med       Date:  2005-03-21       Impact factor: 14.307

View more
  77 in total

Review 1.  Induction of protective immunity against cryptococcosis.

Authors:  Karen L Wozniak; Sarah Hardison; Michal Olszewski; Floyd L Wormley
Journal:  Mycopathologia       Date:  2011-12-06       Impact factor: 2.574

2.  Heterogeneity of lung mononuclear phagocytes during pneumonia: contribution of chemokine receptors.

Authors:  Lanlin Chen; Zhimin Zhang; Kathryn E Barletta; Marie D Burdick; Borna Mehrad
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-09-20       Impact factor: 5.464

Review 3.  Complexity of dendritic cell subsets and their function in the host immune system.

Authors:  Rahul Kushwah; Jim Hu
Journal:  Immunology       Date:  2011-06-01       Impact factor: 7.397

4.  Early induction of CCL7 downstream of TLR9 signaling promotes the development of robust immunity to cryptococcal infection.

Authors:  Yafeng Qiu; Stuart Zeltzer; Yanmei Zhang; Fuyuan Wang; Gwo-Hsiao Chen; Jeremy Dayrit; Benjamin J Murdock; Urvashi Bhan; Galen B Toews; John J Osterholzer; Theodore J Standiford; Michal A Olszewski
Journal:  J Immunol       Date:  2012-03-14       Impact factor: 5.422

5.  Cryptococcal heat shock protein 70 homolog Ssa1 contributes to pulmonary expansion of Cryptococcus neoformans during the afferent phase of the immune response by promoting macrophage M2 polarization.

Authors:  Alison J Eastman; Xiumiao He; Yafeng Qiu; Michael J Davis; Priya Vedula; Daniel M Lyons; Yoon-Dong Park; Sarah E Hardison; Antoni N Malachowski; John J Osterholzer; Floyd L Wormley; Peter R Williamson; Michal A Olszewski
Journal:  J Immunol       Date:  2015-05-13       Impact factor: 5.422

6.  Local GM-CSF-Dependent Differentiation and Activation of Pulmonary Dendritic Cells and Macrophages Protect against Progressive Cryptococcal Lung Infection in Mice.

Authors:  Gwo-Hsiao Chen; Seagal Teitz-Tennenbaum; Lori M Neal; Benjamin J Murdock; Antoni N Malachowski; Anthony J Dils; Michal A Olszewski; John J Osterholzer
Journal:  J Immunol       Date:  2016-01-11       Impact factor: 5.422

Review 7.  Innate host defenses against Cryptococcus neoformans.

Authors:  Camaron Hole; Floyd L Wormley
Journal:  J Microbiol       Date:  2016-02-27       Impact factor: 3.422

8.  Interleukin-17A enhances host defense against cryptococcal lung infection through effects mediated by leukocyte recruitment, activation, and gamma interferon production.

Authors:  Benjamin J Murdock; Gary B Huffnagle; Michal A Olszewski; John J Osterholzer
Journal:  Infect Immun       Date:  2013-12-09       Impact factor: 3.441

9.  Deficiency of lymph node-resident dendritic cells (DCs) and dysregulation of DC chemoattractants in a malnourished mouse model of Leishmania donovani infection.

Authors:  Marwa K Ibrahim; Jeffrey L Barnes; E Yaneth Osorio; Gregory M Anstead; Fabio Jimenez; John J Osterholzer; Bruno L Travi; Seema S Ahuja; A Clinton White; Peter C Melby
Journal:  Infect Immun       Date:  2014-05-12       Impact factor: 3.441

10.  Periostin is required for maximal airways inflammation and hyperresponsiveness in mice.

Authors:  J Kelley Bentley; Qiang Chen; Jun Young Hong; Antonia P Popova; Jing Lei; Bethany B Moore; Marc B Hershenson
Journal:  J Allergy Clin Immunol       Date:  2014-07-02       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.